Enfusion Total Assets from 2010 to 2025
| ENFN Stock | USD 11.10 0.01 0.09% |
Total Assets | First Reported 2010-12-31 | Previous Quarter 143.3 M | Current Value 99.8 M | Quarterly Volatility 45 M |
Check Enfusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enfusion's main balance sheet or income statement drivers, such as Tax Provision of 3.6 M, Net Interest Income of 1.8 M or Depreciation And Amortization of 12.1 M, as well as many indicators such as Price To Sales Ratio of 4.47, Dividend Yield of 0.0034 or PTB Ratio of 13.6. Enfusion financial statements analysis is a perfect complement when working with Enfusion Valuation or Volatility modules.
Enfusion | Total Assets |
Latest Enfusion's Total Assets Growth Pattern
Below is the plot of the Total Assets of Enfusion over the last few years. Total assets refers to the total amount of Enfusion assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Enfusion books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Enfusion's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enfusion's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 143.26 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Enfusion Total Assets Regression Statistics
| Arithmetic Mean | 53,311,007 | |
| Geometric Mean | 39,567,393 | |
| Coefficient Of Variation | 84.41 | |
| Mean Deviation | 39,419,010 | |
| Median | 23,197,000 | |
| Standard Deviation | 44,998,410 | |
| Sample Variance | 2024.9T | |
| Range | 120.1M | |
| R-Value | 0.81 | |
| Mean Square Error | 739.2T | |
| R-Squared | 0.66 | |
| Significance | 0.0001 | |
| Slope | 7,674,256 | |
| Total Sum of Squares | 30372.9T |
Enfusion Total Assets History
Other Fundumenentals of Enfusion
Enfusion Total Assets component correlations
Click cells to compare fundamentals
About Enfusion Financial Statements
Enfusion investors utilize fundamental indicators, such as Total Assets, to predict how Enfusion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 143.3 M | 99.8 M |
Check out the analysis of Enfusion Correlation against competitors. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share 0.03 | Revenue Per Share | Quarterly Revenue Growth 0.139 | Return On Assets |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.